An Evolutionary Framework for Treating Pediatric Sarcomas

Overview

Journal Cancer

Publisher Wiley

Specialty Oncology

Date 2020 Mar 17

PMID 32176331

Citations 27

Authors

Damon R Reed

Jonathan Metts

Mariyah Pressley

Brooke L Fridley

Masanori Hayashi

Michael S Isakoff

David M Loeb

Rikesh Makanji

Ryan D Roberts

Matteo Trucco

Lars M Wagner

Mark G Alexandrow

Robert A Gatenby

Joel S Brown

Affiliations

Soon will be listed here.

Citing Articles

The effect of tumor composition on the success of adaptive therapy: The case of metastatic Castrate-Resistant Prostate Cancer.

Salvioli M, Vandelaer L, Baena E, Schneider K, Cavill R, Stankova K PLoS One. 2024; 19(9):e0308173.

PMID: 39325718 PMC: 11426540. DOI: 10.1371/journal.pone.0308173.

Ecological and evolutionary dynamics to design and improve ovarian cancer treatment.

Han G, Alexander M, Gattozzi J, Day M, Kirsch E, Tafreshi N Clin Transl Med. 2024; 14(9):e70012.

PMID: 39210542 PMC: 11362027. DOI: 10.1002/ctm2.70012.

An evolutionary differential game for regulating the role of monoclonal antibodies in treating signalling pathways in oesophageal cancer.

Alajmi M, Roy S R Soc Open Sci. 2024; 11(7):240347.

PMID: 39086820 PMC: 11289643. DOI: 10.1098/rsos.240347.

Roadmap for the next generation of Children's Oncology Group rhabdomyosarcoma trials.

Metts J, Aye J, Crane J, Oberoi S, Balis F, Bhatia S Cancer. 2024; 130(22):3785-3796.

PMID: 38941509 PMC: 11511643. DOI: 10.1002/cncr.35457.

A war on many fronts: cross disciplinary approaches for novel cancer treatment strategies.

Del Pino Herrera A, Ferrall-Fairbanks M Front Genet. 2024; 15:1383676.

PMID: 38873108 PMC: 11169904. DOI: 10.3389/fgene.2024.1383676.

References

Rosenberg A, Anderson J, Lyden E, Rodeberg D, Wolden S, Kao S . Early response as assessed by anatomic imaging does not predict failure-free survival among patients with Group III rhabdomyosarcoma: a report from the Children's Oncology Group. Eur J Cancer. 2013; 50(4):816-23. PMC: 3944684. DOI: 10.1016/j.ejca.2013.11.031. View

Abbou S, Shulman D, Dubois S, Crompton B . Assessment of circulating tumor DNA in pediatric solid tumors: The promise of liquid biopsies. Pediatr Blood Cancer. 2019; 66(5):e27595. PMC: 6550461. DOI: 10.1002/pbc.27595. View

Estrella V, Chen T, Lloyd M, Wojtkowiak J, Cornnell H, Ibrahim-Hashim A . Acidity generated by the tumor microenvironment drives local invasion. Cancer Res. 2013; 73(5):1524-35. PMC: 3594450. DOI: 10.1158/0008-5472.CAN-12-2796. View

Bielack S, Smeland S, Whelan J, Marina N, Jovic G, Hook J . Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good.... J Clin Oncol. 2015; 33(20):2279-87. PMC: 4486345. DOI: 10.1200/JCO.2014.60.0734. View

Ibrahim-Hashim A, Robertson-Tessi M, Enriquez-Navas P, Damaghi M, Balagurunathan Y, Wojtkowiak J . Defining Cancer Subpopulations by Adaptive Strategies Rather Than Molecular Properties Provides Novel Insights into Intratumoral Evolution. Cancer Res. 2017; 77(9):2242-2254. PMC: 6005351. DOI: 10.1158/0008-5472.CAN-16-2844. View

Weigel B, Lyden E, Anderson J, Meyer W, Parham D, Rodeberg D . Intensive Multiagent Therapy, Including Dose-Compressed Cycles of Ifosfamide/Etoposide and Vincristine/Doxorubicin/Cyclophosphamide, Irinotecan, and Radiation, in Patients With High-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group. J Clin Oncol. 2015; 34(2):117-22. PMC: 5070550. DOI: 10.1200/JCO.2015.63.4048. View

Stewart E, Federico S, Chen X, Shelat A, Bradley C, Gordon B . Orthotopic patient-derived xenografts of paediatric solid tumours. Nature. 2017; 549(7670):96-100. PMC: 5659286. DOI: 10.1038/nature23647. View

Mascarenhas L, Chi Y, Hingorani P, Anderson J, Lyden E, Rodeberg D . Randomized Phase II Trial of Bevacizumab or Temsirolimus in Combination With Chemotherapy for First Relapse Rhabdomyosarcoma: A Report From the Children's Oncology Group. J Clin Oncol. 2019; 37(31):2866-2874. PMC: 6823886. DOI: 10.1200/JCO.19.00576. View

HUSTU H, Pinkel D, Pratt C . Treatment of clinically localized Ewing's sarcoma with radiotherapy and combination chemotherapy. Cancer. 1972; 30(6):1522-7. DOI: 10.1002/1097-0142(197212)30:6<1522::aid-cncr2820300617>3.0.co;2-j. View

10.

Kuttesch Jr J, Krailo M, Madden T, Johansen M, Bleyer A . Phase II evaluation of intravenous vinorelbine (Navelbine) in recurrent or refractory pediatric malignancies: a Children's Oncology Group study. Pediatr Blood Cancer. 2009; 53(4):590-3. PMC: 2754403. DOI: 10.1002/pbc.22133. View

11.

Reed D, Hayashi M, Wagner L, Binitie O, Steppan D, Brohl A . Treatment pathway of bone sarcoma in children, adolescents, and young adults. Cancer. 2017; 123(12):2206-2218. PMC: 5485018. DOI: 10.1002/cncr.30589. View

12.

Gillies R, Gatenby R . Hypoxia and adaptive landscapes in the evolution of carcinogenesis. Cancer Metastasis Rev. 2007; 26(2):311-7. DOI: 10.1007/s10555-007-9065-z. View

13.

Gorlick R, Janeway K, Lessnick S, Randall R, Marina N . Children's Oncology Group's 2013 blueprint for research: bone tumors. Pediatr Blood Cancer. 2012; 60(6):1009-15. PMC: 4610028. DOI: 10.1002/pbc.24429. View

14.

Gillies R, Brown J, Anderson A, Gatenby R . Eco-evolutionary causes and consequences of temporal changes in intratumoural blood flow. Nat Rev Cancer. 2018; 18(9):576-585. PMC: 6441333. DOI: 10.1038/s41568-018-0030-7. View

15.

Coustan-Smith E, Sancho J, Hancock M, Boyett J, Behm F, Raimondi S . Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia. Blood. 2000; 96(8):2691-6. View

16.

Gillies R, Kinahan P, Hricak H . Radiomics: Images Are More than Pictures, They Are Data. Radiology. 2015; 278(2):563-77. PMC: 4734157. DOI: 10.1148/radiol.2015151169. View

17.

Gatenby R, Gillies R . Why do cancers have high aerobic glycolysis?. Nat Rev Cancer. 2004; 4(11):891-9. DOI: 10.1038/nrc1478. View

18.

Stewart E, Goshorn R, Bradley C, Griffiths L, Benavente C, Twarog N . Targeting the DNA repair pathway in Ewing sarcoma. Cell Rep. 2014; 9(3):829-41. PMC: 4386669. DOI: 10.1016/j.celrep.2014.09.028. View

19.

Woods W, Kobrinsky N, Buckley J, Lee J, Sanders J, Neudorf S . Timed-sequential induction therapy improves postremission outcome in acute myeloid leukemia: a report from the Children's Cancer Group. Blood. 1996; 87(12):4979-89. View

20.

Gatenby R, Zhang J, Brown J . First Strike-Second Strike Strategies in Metastatic Cancer: Lessons from the Evolutionary Dynamics of Extinction. Cancer Res. 2019; 79(13):3174-3177. PMC: 6606376. DOI: 10.1158/0008-5472.CAN-19-0807. View